MEDICAL DIAGNOSTICS & LABS

Medical Diagnostics Brand Perception & Laboratory Head Evaluation Survey

Map how laboratory heads evaluate, compare, and choose diagnostic brand partners across reagent reliability, service responsiveness, and equipment performance, so you can sharpen acquisition messaging, fix retention gaps, and benchmark your positioning against competing suppliers.

Pan-India sample
Laboratory Heads (Senior Lab Decision-Makers)
15-20 min
Talk to a Survey Consultant
Brand switching & conversion gapsIdentify where laboratory heads disengage, stall, or switch diagnostic suppliers.
Selection drivers & pricing sensitivityRank the criteria, cost thresholds, and contract terms that determine supplier preference.
TRUSTED BY LEADING BRANDS
Brand 0Brand 1Brand 2Brand 3Brand 4Brand 5Brand 6Brand 7Brand 8Brand 9Brand 10Brand 11Brand 12Brand 13Brand 14Brand 15Brand 16Brand 17Brand 18Brand 19Brand 20Brand 21Brand 22Brand 23Brand 24Brand 25Brand 26Brand 27Brand 28Brand 29Brand 30Brand 31

CONTEXT & RELEVANCE

Why run this survey now

Most diagnostics brands don't lose laboratory accounts purely on reagent pricing. They lose them due to inconsistent field support, weak clinical credibility, poor instrument uptime records, misaligned consumable bundling, and unrecognized brand equity gaps, none of which fully show up in sales rep call logs or distributor offtake reports.

If you are...

  • Diagnostics brand vs private lab chain
  • IVD portfolio head, brand positioning
  • Lab head evaluating reagent suppliers
  • Regional sales or territory manager
  • Diagnostics strategy or planning lead

You're likely facing...

  • Brand recall gap: urban vs tier-2 labs
  • Instrument trial to conversion drop-off
  • Reagent loyalty vs price sensitivity tension
  • Competing brands = reliable/inflexible perception
  • Renewal risk: service response gaps

This will help answer...

  • Brand preference drivers beyond price
  • Trial-to-adoption conversion barriers
  • Lab segment switching triggers
  • Service vs clinical credibility weighting
  • Renewal risk and loyalty signals

RESEARCH THEMES

What This Survey Investigates

Eight interconnected research themes that map the complete laboratory head journey from brand awareness to procurement commitment.

TENETS 01

Brand Awareness & Recall

  • Unaided brand recall, diagnostics segment
  • First-heard channel, reagent brands
TENETS 02

Preference Drivers

  • Assay performance, procurement shortlisting criteria
  • Technical support weight, vendor selection
TENETS 03

Portfolio & Fit

  • Reagent menu breadth, lab workflow coverage
  • Instrument-reagent compatibility gaps
TENETS 04

Procurement Friction

  • Order-to-delivery lead time, stockout frequency
  • Tender documentation burden, public sector labs
TENETS 05

Pricing & Contracts

  • Reagent rental model vs. outright purchase preference
  • Volume-based pricing thresholds, annual contracts
TENETS 06

Service & Support

  • Field application specialist responsiveness, breakdown SLA
  • Remote diagnostics support, instrument uptime
TENETS 07

Trust & Credibility

  • Regulatory certification weight, brand trust signals
  • Peer validation, key opinion leader endorsement
TENETS 08

Competitive Positioning

  • Brand switching triggers, incumbent displacement patterns
  • Multi-brand coexistence, consolidation intent

SAMPLING STRATEGY

Tell us about your ideal sample

Help us understand your target respondent profile. Select what applies, we'll design the optimal sample plan based on your inputs.

Sample size
How many respondents do you need?
Not Selected
Target audience
Who should we survey?
Not Selected
Region
Which regions should we cover?
Not Selected
Segments
How should we slice the data?
Not Selected
Discuss sample plan

METHODOLOGY

Survey approach

For the Medical Diagnostics Brand Perception & Laboratory Head Evaluation Survey, we recommend a quant-first design with flexible data-collection modes to balance reach, depth, and verification.

PRIMARY
Online web surveySelf-administered survey shared via email / panels to capture structured responses at scale.
Best for
1
Ranking diagnostic brand preference by lab type
2
Measuring reagent and equipment satisfaction scores
3
Comparing segments by lab size and specialty
Deliverables
Brand preference ranking
Satisfaction gap matrix
Segment comparison report
OPTIONAL
CATI (phone survey)Interviewer-led telephone interviews to reach owners who are harder to get online.
Best for
1
Standalone labs with low digital engagement
2
Rapid coverage across Tier 2 and Tier 3 cities
Deliverables
Lab-type coverage map
Call-log diagnostics
SELECTIVE
Face-to-faceOn-ground surveys or interviews in key industrial clusters or high-value cohorts.
Best for
1
High-volume reference labs requiring procurement verification
2
Hospital-embedded labs with complex buying committees
Deliverables
Procurement journey maps
High-value lab profiles
OPTIONAL
FGDs
Deliverables
Verbatim themes
Positioning feedback
OPTIONAL
Mixed surveysAny 4-mode combo Online + CATI + F2F + FGDs to maximise reach and representation. Mode-specific quotas and weighting for clean comparisons.
Deliverables
Unified dataset
Mode-adjusted analytics
Our Recommendation
Start with: Online web survey as the core quant layer, targeting laboratory heads across standalone, chain, and hospital-embedded labs, supported by CATI for Tier 2 and Tier 3 facilities with low digital access.
Consider adding: Face-to-face interviews for high-volume reference labs and a focused FGD layer to pressure-test brand positioning and identify switching triggers among senior lab decision-makers.

EXECUTION PROCESS

How we execute

A proven 9-step process from scoping to delivery, designed to ensure quality, speed, and actionable insights.

Define the decision frame

Confirm objectives, target cohorts, geographies, and reporting cuts

Step 01

Define the decision frame

Design the instrument

Build workstream modules mapped to outputs (drivers, friction, pricing, retention, trust)

Step 02

Design the instrument

Lock the questionnaire

Review wording, sequencing, LOI, and competitive context; approve final version

Step 03

Lock the questionnaire

Pilot and calibrate

Test comprehension and ease quality; refine quotas and remove friction where needed

Step 04

Pilot and calibrate

Run fieldwork

Execute collection with active quota management and feasibility controls

Step 05

Run fieldwork

Assure quality

Dedupe, attention checks, speed/consistency rules, removals with audit trail

Step 06

Assure quality

Prepare the dataset

Clean data and deliver codebook/variable definitions

Step 07

Prepare the dataset

Analyse and synthesise

Driver ranking, leakage diagnostics, pricing bands, segment insights

Step 08

Analyse and synthesise

Deliver and align

Executive deck (optional dashboard) and leadership readout with recommendations

Step 09

Deliver and align

COMMERCIAL TERMS

Request a Commercial Proposal

Pricing depends on cohort, geography, sample size, approach, LOI, and deliverables. Configure below for an indicative estimate.

Select Sample Size

100

Geography

  • India
  • APAC (Singapore, Vietnam, Philippines, Indonesia, Australia, NZ, Japan, Thailand)
  • Middle East (UAE, KSA, Qatar, Bahrain, Oman, Kuwait)
  • North America (US, Canada)
  • Europe
  • Africa (South Africa, Kenya, Nigeria, Egypt, Algeria)
  • LATAM (Brazil, Mexico)

Select Mode of Survey

  • Online
  • CATI
  • Online FGD (5 people per FGD)
  • F2F

Length of the Interview

  • Select
  • 0-15
  • 16-20
  • 21-30
  • 31-45
  • 46-60
  • Custom
Indicative Estimate
  • Indian Rupee (INR)
  • United Arab Emirates Dirham (AED)
  • Afghan Afghani (AFN)
  • Albanian Lek (ALL)
  • Armenian Dram (AMD)
  • Netherlands Antillean Guilder (ANG)
  • Angolan Kwanza (AOA)
  • Argentine Peso (ARS)
  • Australian Dollar (AUD)
  • Aruban Florin (AWG)
  • Azerbaijani Manat (AZN)
  • Bosnia-Herzegovina Convertible Mark (BAM)
  • Barbadian Dollar (BBD)
  • Bangladeshi Taka (BDT)
  • Bulgarian Lev (BGN)
  • Bahraini Dinar (BHD)
  • Burundian Franc (BIF)
  • Bermudian Dollar (BMD)
  • Brunei Dollar (BND)
  • Bolivian Boliviano (BOB)
  • Brazilian Real (BRL)
  • Bahamian Dollar (BSD)
  • Bhutanese Ngultrum (BTN)
  • Botswana Pula (BWP)
  • Belarusian Ruble (BYN)
  • Belize Dollar (BZD)
  • Canadian Dollar (CAD)
  • Congolese Franc (CDF)
  • Swiss Franc (CHF)
  • Chilean Peso (CLP)
  • Chinese Yuan (CNY)
  • Colombian Peso (COP)
  • Costa Rican Colón (CRC)
  • Cuban Peso (CUP)
  • Cape Verdean Escudo (CVE)
  • Czech Koruna (CZK)
  • Djiboutian Franc (DJF)
  • Danish Krone (DKK)
  • Dominican Peso (DOP)
  • Algerian Dinar (DZD)
  • Egyptian Pound (EGP)
  • Eritrean Nakfa (ERN)
  • Ethiopian Birr (ETB)
  • Euro (EUR)
  • Fijian Dollar (FJD)
  • Falkland Islands Pound (FKP)
  • British Pound (GBP)
  • Georgian Lari (GEL)
  • Ghanaian Cedi (GHS)
  • Gibraltar Pound (GIP)
  • Gambian Dalasi (GMD)
  • Guinean Franc (GNF)
  • Guatemalan Quetzal (GTQ)
  • Guyanese Dollar (GYD)
  • Hong Kong Dollar (HKD)
  • Honduran Lempira (HNL)
  • Croatian Kuna (HRK)
  • Haitian Gourde (HTG)
  • Hungarian Forint (HUF)
  • Indonesian Rupiah (IDR)
  • Israeli New Shekel (ILS)
  • Iraqi Dinar (IQD)
  • Iranian Rial (IRR)
  • Icelandic Króna (ISK)
  • Jamaican Dollar (JMD)
  • Jordanian Dinar (JOD)
  • Japanese Yen (JPY)
  • Kenyan Shilling (KES)
  • Kyrgyzstani Som (KGS)
  • Cambodian Riel (KHR)
  • Comorian Franc (KMF)
  • South Korean Won (KRW)
  • Kuwaiti Dinar (KWD)
  • Cayman Islands Dollar (KYD)
  • Kazakhstani Tenge (KZT)
  • Lao Kip (LAK)
  • Lebanese Pound (LBP)
  • Sri Lankan Rupee (LKR)
  • Liberian Dollar (LRD)
  • Lesotho Loti (LSL)
  • Libyan Dinar (LYD)
  • Moroccan Dirham (MAD)
  • Moldovan Leu (MDL)
  • Malagasy Ariary (MGA)
  • Macedonian Denar (MKD)
  • Burmese Kyat (MMK)
  • Mongolian Tögrög (MNT)
  • Macanese Pataca (MOP)
  • Mauritian Rupee (MUR)
  • Maldivian Rufiyaa (MVR)
  • Malawian Kwacha (MWK)
  • Mexican Peso (MXN)
  • Malaysian Ringgit (MYR)
  • Mozambican Metical (MZN)
  • Namibian Dollar (NAD)
  • Nigerian Naira (NGN)
  • Nicaraguan Córdoba (NIO)
  • Norwegian Krone (NOK)
  • Nepalese Rupee (NPR)
  • New Zealand Dollar (NZD)
  • Omani Rial (OMR)
  • Panamanian Balboa (PAB)
  • Peruvian Sol (PEN)
  • Papua New Guinean Kina (PGK)
  • Philippine Peso (PHP)
  • Pakistani Rupee (PKR)
  • Polish Złoty (PLN)
  • Paraguayan Guaraní (PYG)
  • Qatari Riyal (QAR)
  • Romanian Leu (RON)
  • Serbian Dinar (RSD)
  • Russian Ruble (RUB)
  • Rwandan Franc (RWF)
  • Saudi Riyal (SAR)
  • Solomon Islands Dollar (SBD)
  • Seychellois Rupee (SCR)
  • Sudanese Pound (SDG)
  • Swedish Krona (SEK)
  • Singapore Dollar (SGD)
  • Saint Helena Pound (SHP)
  • Sierra Leonean Leone (SLL)
  • Somali Shilling (SOS)
  • Surinamese Dollar (SRD)
  • São Tomé and Príncipe Dobra (STD)
  • Syrian Pound (SYP)
  • Swazi Lilangeni (SZL)
  • Thai Baht (THB)
  • Tajikistani Somoni (TJS)
  • Turkmenistani Manat (TMT)
  • Tunisian Dinar (TND)
  • Tongan Paʻanga (TOP)
  • Turkish Lira (TRY)
  • Trinidad and Tobago Dollar (TTD)
  • New Taiwan Dollar (TWD)
  • Tanzanian Shilling (TZS)
  • Ukrainian Hryvnia (UAH)
  • Ugandan Shilling (UGX)
  • United States Dollar (USD)
  • Uruguayan Peso (UYU)
  • Uzbekistani Som (UZS)
  • Vietnamese Đồng (VND)
  • Vanuatu Vatu (VUV)
  • Samoan Tālā (WST)
  • Central African CFA Franc (XAF)
  • East Caribbean Dollar (XCD)
  • West African CFA franc (XOF)
  • CFP Franc (XPF)
  • Yemeni Rial (YER)
  • South African Rand (ZAR)
  • Zambian Kwacha (ZMW)
  • Zimbabwean Dollar (ZWL)

$0.00

+ applicable taxes

Proposal turnaround typically 24–48 hours

Note: Estimate is indicative only. Final pricing is subject to scope finalization after discovery call.

REFERENCE CASELETS

Reference

Real-world examples of survey work in the medical diagnostics and laboratory services space.

CASELET 1

Diagnostic brand recall & preference mapping among pathologists (India)

CASELET 2

Equipment vendor evaluation criteria & messaging territories (South Asia)

Diagnostic brand recall & preference mapping among pathologists (India)

OBJECTIVE

A mid-size in-vitro diagnostics manufacturer needed to map how consultant pathologists and independent laboratory owners rank reagent brands on reliability, turnaround consistency, and technical support responsiveness when making annual procurement decisions.

WHAT WE DID

Ran a structured quant survey across 240 laboratory professionals in 8 Indian cities, capturing brand shortlists, primary switch triggers, preferred distributor channels, and price sensitivity thresholds by laboratory tier and monthly test volume band.

DELIVERED

A brand preference map by laboratory tier, a switching trigger framework ranked by frequency and severity, a pricing corridor by reagent category, and a set of channel levers to convert distributor-dependent buyers into direct accounts.
CASELET 1

Diagnostic brand recall & preference mapping among pathologists (India)

CASELET 2

Equipment vendor evaluation criteria & messaging territories (South Asia)

Diagnostic brand recall & preference mapping among pathologists (India)

OBJECTIVE

A mid-size in-vitro diagnostics manufacturer needed to map how consultant pathologists and independent laboratory owners rank reagent brands on reliability, turnaround consistency, and technical support responsiveness when making annual procurement decisions.

WHAT WE DID

Ran a structured quant survey across 240 laboratory professionals in 8 Indian cities, capturing brand shortlists, primary switch triggers, preferred distributor channels, and price sensitivity thresholds by laboratory tier and monthly test volume band.

DELIVERED

A brand preference map by laboratory tier, a switching trigger framework ranked by frequency and severity, a pricing corridor by reagent category, and a set of channel levers to convert distributor-dependent buyers into direct accounts.

FREQUENTLY ASKED QUESTIONS

Common Questions

Answers to frequently asked questions about this survey mandate.

What decisions will this survey enable?

Who is the buyer vs who are the respondents?

Can we see differences between standalone pathology labs, hospital-integrated labs and diagnostic chain labs?

How will you measure brand preference beyond simple ratings?

Will the survey map the full diagnostics procurement journey and drop-offs?

Can this survey inform product and pricing strategy?

How will findings improve our brand positioning and key account conversion?

Still have questions?

Schedule a discovery call to discuss your specific needs and get a custom quote.

Book a Discovery Call